Yingying Mao, Ph.D.
|2009||Physiology||Temple University, Philadelphia, PA, United States|
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Mao Y, Kunapuli SP. (2013) Trypsin causes platelet activation independently of known protease-activated receptors. Thrombosis and Haemostasis. 110: 1241-9|
|Getz TM, Manne BK, Buitrago L, et al. (2013) Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets. Thrombosis and Haemostasis. 109: 1131-40|
|Mao Y, Zhang L, Jin J, et al. (2010) Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. European Journal of Pharmacology. 644: 10-6|
|Mao Y, Zhang M, Tuma RF, et al. (2010) Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1044-52|
|Mao Y, Jin J, Daniel JL, et al. (2009) Regulation of plasmin-induced protease-activated receptor 4 activation in platelets. Platelets. 20: 191-8|
|Chari R, Getz T, Nagy B, et al. (2009) Protein kinase C[delta] differentially regulates platelet functional responses. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 699-705|
|Jin J, Mao Y, Thomas D, et al. (2009) RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets. Biochemical Pharmacology. 77: 835-44|
|Mao Y, Jin J, Kunapuli SP. (2008) Characterization of a new peptide agonist of the protease-activated receptor-1. Biochemical Pharmacology. 75: 438-47|